ImmuCell Corporation

NasdaqCM ICCC

ImmuCell Corporation Dividend Yield on February 06, 2025

ImmuCell Corporation Dividend Yield is NA on February 06, 2025, a NA change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

ImmuCell Corporation 52-week high Dividend Yield is 0.00% on January 16, 2025, which is NA below the current Dividend Yield.
ImmuCell Corporation 52-week low Dividend Yield is 0.00% on January 16, 2025, which is NA below the current Dividend Yield.
ImmuCell Corporation average Dividend Yield for the last 52 weeks is 0.00%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqCM: ICCC

ImmuCell Corporation

CEO	Mr. Michael F. Brigham
IPO Date	May 5, 1987
Location	United States
Headquarters	56 Evergreen Drive
Employees	75
Sector	Consumers Staples
Industries Dairy & Milk Baby & Childcare Cleaning Supplies Frozen Foods Meat Personal Care Pet Food Vaccines

Description

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Key trends

Past 5 years